Further to my comment above. As a "rule of thumb" MRP only becomes a value buy if it is about half the share price of IRC, or less, of course.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025